Adaptive Biotechnologies

Adaptive Biotechnologies

ADPT· Manufacturing· Fiscal year ends in December

CEO pay in FY2023Stock -35.9% in FY2023

Chad Robins is the CEO of Adaptive Biotechnologies and was paid $8.9M in FY2023 (Dec), up 1%.

Pay$100 in the stock at the end of FY20 → $8
CEO pay is from each Adaptive Biotechnologies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Chad RobinsFY2023
  2. 2Harlan Robins, PhDFY2022
  3. 3Julie RubinsteinFY2023
  4. 4Susan BobulskyFY2024
  5. 5Kyle PiskelFY2023

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Adaptive Biotechnologies paid its one named executive on file $1.7M in FY2024 (Dec).

Name
Susan BobulskyChief Commercial Officer, MRDNot disclosed
Chad RobinsChief Executive Officer and ChairmanNot disclosed
Harlan Robins, PhDChief Scientific OfficerNot disclosedNot disclosed
Julie RubinsteinPresident and Chief Operating OfficerNot disclosed
Kyle PiskelChief Financial OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2025 (Dec) proxy of Adaptive Biotechnologies names 19 peer companies for pay. Among Adaptive Biotechnologies and these peers, CEO pay was 4th highest of 5 and total shareholder return was the lowest of 5.

4th highest of 5in Adaptive Biotechnologies and its pay peers, FY2025 (Dec) by CEO pay:

$7.4M$15.0M

5th highest of 5in Adaptive Biotechnologies and its pay peers, FY2025 (Dec) by total shareholder return:

$27$230

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Robert HershbergDirector · 11 yr on the boardIndependentCompensation and Human Capital (Chair)—Paid as an executive

The board of the latest proxy (FY2024).

Activity

Filings6

See all
Proxy statementDEF 14AApr 24, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 29, 2025FY2024
Annual report10-KMar 3, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KFeb 29, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data